Table 2.
LF peptide sequence | Relative binding affinity of peptide to HLA-DR molecules |
||||||
---|---|---|---|---|---|---|---|
DR1 | DR3 | DR4 | DR7 | DR11 | DR13 | DR15 | |
111 GGKIYIVDGDITKHISLEAL 130 | 122 | >1000 | 61 | 15 | 75 | 21 | 6 |
161 VLVIQSSEDYVENTEKALNV 180 | 1702 | 82 | 29 | 66 | 168 | >172 | 958 |
181 YYEIGKILSRDILSKINQPY 200 | 69 | 3 | 19 | 4 | 0.4 | 5 | 43 |
221 LLFTNQLKEHPTDFSVEFLE 240 | 909 | >76 | 6 | 51 | 148 | >172 | 193 |
The relative binding affinity of peptides to HLA-DR molecules were expressed as a relative activity (ratio of the IC50 of the peptide to the IC50 of a reference peptide which binds strongly to the individual HLA II molecule). Peptides with a high relative binding affinity of <10 are indicated in bold, while moderate binding is characterized by a range of relative affinity varying from 10 to 100. Means were calculated from at least three independent measurements.